Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 9
2016 5
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Aromatase inhibitors in the pharmacotherapy of endometriosis.
Gardella B, Rispoli E, Pasquali MF, Mauri M, Musacchi V, Dominoni M. Gardella B, et al. Among authors: musacchi v. Expert Opin Pharmacother. 2023 Jun;24(9):1067-1073. doi: 10.1080/14656566.2023.2209315. Epub 2023 May 3. Expert Opin Pharmacother. 2023. PMID: 37128968 Review.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Oxaliplatin for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: musacchi v. Expert Opin Investig Drugs. 2015;24(9):1275-86. doi: 10.1517/13543784.2015.1062874. Epub 2015 Jun 30. Expert Opin Investig Drugs. 2015. PMID: 26125301 Review.
Veliparib for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Dominoni M, Musacchi V, Venturini PL, Spinillo A, Ferrero S, Gardella B. Bogliolo S, et al. Among authors: musacchi v. Expert Opin Investig Drugs. 2016;25(3):367-74. doi: 10.1517/13543784.2016.1146677. Epub 2016 Feb 16. Expert Opin Investig Drugs. 2016. PMID: 26807493 Review.
Current opinion on bevacizumab on endometrial cancer treatment.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: musacchi v. Expert Opin Biol Ther. 2015 Feb;15(2):299-307. doi: 10.1517/14712598.2015.995624. Epub 2014 Dec 24. Expert Opin Biol Ther. 2015. PMID: 25539414
Analysis of surgical outcomes and learning curve of surgical parameters for robotic hysterectomy: a comparison between multiport versus single-site.
Gardella B, Dominoni M, Gritti A, Musacchi V, Stracquadaini M, Bogliolo S, Scudeller L, Spinillo A. Gardella B, et al. Among authors: musacchi v. Minim Invasive Ther Allied Technol. 2022 Aug;31(6):954-961. doi: 10.1080/13645706.2022.2045325. Epub 2022 Feb 28. Minim Invasive Ther Allied Technol. 2022. PMID: 35225752 Clinical Trial.
21 results